<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4">Coxiella burnetti – Q fever</h1><h2 class="text-xl font-semibold mt-6 mb-3"><strong>1. Overview &amp; Taxonomy</strong></h2><ul><li>Small, pleomorphic, <strong>Gram-negative coccobacillus</strong>.</li><li><strong>Obligate intracellular</strong> (replicates in acidic phagolysosomes of host cells, esp. macrophages).</li><li>Two morphologic variants:<ul><li><strong>Small Cell Variant (SCV)</strong> — metabolically inactive, environmentally resistant; survives months–years in dust, wool, milk.</li><li><strong>Large Cell Variant (LCV)</strong> — metabolically active.</li></ul></li><li><strong>Non-motile</strong>, no flagella.</li><li><strong>Antigenic phases</strong> (LPS variation):<ul><li><strong>Phase I</strong> — smooth LPS, virulent, found in nature.</li><li><strong>Phase II</strong> — rough LPS, avirulent, seen after in vitro passage.</li></ul></li><li><strong>Reservoirs</strong>: sheep, goats, cattle (primary); also cats, dogs, wild mammals, birds, ticks.</li><li><strong>Transmission</strong>:<ul><li>Aerosolised particles from birth products, urine, faeces, milk.</li><li>Raw milk ingestion possible (less common).</li><li>Very low infectious dose (~1 organism).</li><li>Rare human-to-human spread.</li></ul></li><li><strong>Epidemiology</strong>: Worldwide; UK notifiable disease.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>2. Laboratory Microbiology</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>A) Safety</strong></h3><ul><li><strong>Hazard Group 3</strong> — highly infectious via aerosols. All culture or manipulation in <strong>BSL-3</strong> containment.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>B) Growth &amp; Culture</strong></h3><ul><li>No growth on routine bacteriological media.</li><li>Requires <strong>eukaryotic host cells</strong>: embryonated eggs, cell lines (e.g., Vero, L929, HeLa), or lab animals.</li><li>Culture performed only in reference labs (never routine).</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>C) Staining</strong></h3><ul><li>Gram stain: faint Gram-negative coccobacilli (often not seen).</li><li><strong>Gimenez stain</strong>: organisms stain red against green background.</li><li><strong>Stamp stain</strong> (modified Ziehl-Neelsen): organisms stain red.</li><li><strong>Immunohistochemistry (IHC)</strong>: detects antigen in tissue (valve, liver) — useful in culture-negative IE.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>D) Molecular Diagnostics</strong></h3><ul><li>PCR is <strong>first-line in early acute infection</strong> (before seroconversion).</li><li>Best specimens:<ul><li>EDTA blood or serum in early acute (&lt;2 wks).</li><li>Tissue from valves, vascular grafts, aneurysms, liver biopsy in chronic disease.</li></ul></li><li>Limitations:<ul><li>Sensitivity declines after 2 weeks in acute infection or after antibiotics.</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>E) Serology (IFA = reference standard)</strong></h3><ul><li>Measures IgG/IgM to Phase I and II antigens.</li><li><strong>Acute Q fever</strong>:<ul><li>High <strong>Phase II</strong> IgG ± IgM; Phase I low or absent early.</li></ul></li><li><strong>Chronic Q fever</strong>:<ul><li>High <strong>Phase I</strong> IgG (≥1:800; lab-specific cut-off), often high Phase II IgG too.</li></ul></li><li>Paired sera (2–3 weeks apart) may be needed — early samples can be negative.</li><li>Cross-reactions: occasional low-level with <em>Legionella</em>, <em>Bartonella</em>, <em>Chlamydophila</em>.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>G) Antimicrobial Susceptibility Testing</strong></h3><ul><li>Not routine — obligate intracellular nature prevents standard MIC testing.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>3. Clinical Syndromes</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>A) Acute Q Fever</strong></h3><ul><li>Incubation: ~2–3 weeks.</li><li>Presentations:<ul><li>Asymptomatic (≈50%).</li><li>Abrupt<strong> flu-like illness</strong>: fever, sweats, headache, myalgia.</li><li><strong>Atypical pneumonia</strong>: non-productive cough, patchy infiltrates.</li><li><strong>Hepatitis</strong>: fever, hepatomegaly, raised transaminases ± jaundice.</li></ul></li><li>Complications: meningoencephalitis, myocarditis, pericarditis.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>B) Chronic Q Fever</strong></h3><ul><li>Occurs in &lt;5% of infections; months–years after acute phase.</li><li>Risk factors: pregnancy, immunosuppression, valvular/vascular abnormalities, prosthetic valves/grafts.</li><li>Most common form: <strong>culture-negative endocarditis</strong>.</li><li>Others: infected aneurysm, vascular graft infection, chronic hepatitis, osteomyelitis.</li><li>High mortality untreated.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>C) Q Fever in Pregnancy</strong></h3><ul><li>Higher maternal and fetal risks: miscarriage, stillbirth, preterm delivery.</li><li>Chronic infection risk increased.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>4. Diagnosis – Practical Summary</strong></h2><table><tr><td><p><strong>Scenario</strong></p></td><td><p><strong>Best test(s)</strong></p></td></tr><tr><td><p>Early acute (&lt;14 d)</p></td><td><p>PCR on EDTA blood ± serum</p></td></tr><tr><td><p>Acute (&gt;14 d)</p></td><td><p>Serology (rise in Phase II IgG/IgM)</p></td></tr><tr><td><p>Chronic Q fever</p></td><td><p>Serology: high Phase I IgG ≥1:800 ± PCR on tissue</p></td></tr><tr><td><p>BCNIE / vascular</p></td><td><p>Coxiella + Bartonella serology; PCR on valve if available</p></td></tr></table><h2 class="text-xl font-semibold mt-6 mb-3"><strong>5. Treatment</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>A) Acute Q Fever</strong></h3><ul><li>Adults: <strong>Doxycycline 100 mg bd × 14 days</strong> (7 days may suffice for uncomplicated pneumonia; use 14 days if hepatitis).</li><li>Pregnancy: <strong>Co-trimoxazole 160/800 mg bd</strong> until delivery (stop ~32–36 wks to avoid folate antagonism).</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>B) Chronic Q Fever (IE/vascular infection)</strong></h3><ul><li><strong>Doxycycline 100 mg bd + Hydroxychloroquine 200 mg tds</strong><ul><li>Duration: ≥18 mo (native valve), ≥24 mo (prosthetic/graft).</li><li>Monitor HCQ levels (target 0.8–1.2 µg/ml) and retinal toxicity.</li><li>Follow Phase I IgG titres — falling titres suggest cure.</li></ul></li><li>If HCQ contraindicated: doxycycline + fluoroquinolone (less effective).</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>C) Post-Exposure Prophylaxis</strong></h3><ul><li>For high-risk exposures (e.g., pregnant lab worker): <strong>Doxycycline 100 mg daily × 5–7 days</strong> within 8–12 days post-exposure.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>6. Prevention &amp; Control</strong></h2><ul><li>No UK-licensed human vaccine (Q-Vax in Australia; whole-cell inactivated; requires pre-vaccine screening).</li><li>Animal control: manage birthing products, pasteurise milk, vaccinate animals in endemic areas.</li><li>Lab: strict BSL-3 containment for culture/high-risk specimens.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>7. Exam Pearls</strong></h2><ul><li>Always request <strong>Coxiella + Bartonella serology</strong> in BCNIE.</li><li>Chronic Q fever = <strong>high Phase I IgG</strong> — a <strong>major Duke-ISCVID criterion</strong> for IE.</li><li>PCR from blood is <strong>early-phase only</strong>; tissue PCR preferred in chronic disease.</li><li>Pregnancy: treat until delivery even if asymptomatic (to reduce fetal loss).</li><li>Phase I vs Phase II serology differentiation is a favourite exam question.</li><li>Extremely infectious: single organism can cause disease; lab safety is critical.</li></ul>
</div>